Meeting
2023 ASCO Breakthrough
Integrating multi-omics features for blood-based multi-cancer early detection.
Authors
Mao Mao
SeekIn Inc., Shenzhen, China
Mao Mao , Shiyong Li , Qingqi Ren , Yi Luan , Weijie Liang , Shuaipeng Geng , Guolin Zhong , Dandan Zhu , Yinyin Chang , Wei Wu , Yingying Zhang , Linfeng Zhang , Yan Wang , Yumin Feng , Bing Wei , Jie Ma , Chaohui Duan , Guanghui Long
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Breast Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Hematologic Malignancies,Thoracic Cancers,Other Malignancies or Topics
Sub Track
Early Detection and Surveillance
Citation
JCO Global Oncology 9, 2023 (suppl 1; abstr 156)
DOI
10.1200/GO.2023.9.Supplement_1.156
Abstract #
156
Poster Bd #
F10
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Development and evaluation of a multi-cancer screening (MCS) test for cancers common in Asia.
First Author: Michelle Pek
Poster
2022 ASCO Annual Meeting
Early detection of cancer using cell-free DNA (cfDNA) size analysis on a multiplexed amplicon-based next-generation sequencing (NGS) platform.
First Author: Yukti Choudhury
Poster
2024 ASCO Annual Meeting
A potential novel therapeutic target for invasive soft tissue sarcoma detected through tumor immune microenvironment and genetic profile analyses.
First Author: Akane Ariga
Poster
2024 ASCO Annual Meeting
Effect of cancer screening with multi-cancer early detection testing and whole body MRI on cancer worry in a high-risk population.
First Author: Dan Raz